| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4642130
Max Phase: Preclinical
Molecular Formula: C17H20N6OS
Molecular Weight: 356.46
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: c1nc(N2CCNCC2)c2sc3nc(N4CCOCC4)ccc3c2n1
Standard InChI: InChI=1S/C17H20N6OS/c1-2-13(22-7-9-24-10-8-22)21-17-12(1)14-15(25-17)16(20-11-19-14)23-5-3-18-4-6-23/h1-2,11,18H,3-10H2
Standard InChI Key: SRMHUPGGBTUUTH-UHFFFAOYSA-N
Associated Targets(non-human)
Beta-glucuronidase 93 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 356.46 | Molecular Weight (Monoisotopic): 356.1419 | AlogP: 1.49 | #Rotatable Bonds: 2 |
| Polar Surface Area: 66.41 | Molecular Species: BASE | HBA: 8 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 8.71 | CX LogP: 2.21 | CX LogD: 0.89 |
| Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.75 | Np Likeness Score: -2.00 |
References
| 1. Awolade P, Cele N, Kerru N, Gummidi L, Oluwakemi E, Singh P.. (2020) Therapeutic significance of β-glucuronidase activity and its inhibitors: A review., 187 [PMID:31835168] [10.1016/j.ejmech.2019.111921] |
Source
Source(1):